T1	Pharmacological_substance 10 21	Gemcitabine
N1000 	Reference T1 MeSH:C056507	Gemcitabine
T2	Pharmacological_substance 163 179	cytotoxic agents
N1001 	Reference T2 MeSH:D003603	cytotoxic agents
T3	Pharmacological_substance 316 330	anthracyclines
N1002 	Reference T3 MeSH:D018943	anthracyclines
T4	Pharmacological_substance 344 355	Gemcitabine
N1003 	Reference T4 MeSH:C056507	Gemcitabine
T5	Pharmacological_substance 497 508	gemcitabine
N1004 	Reference T5 MeSH:C056507	gemcitabine
T6	Pharmacological_substance 587 598	gemcitabine
N1005 	Reference T6 MeSH:C056507	gemcitabine
T7	Pharmacological_substance 651 665	anthracyclines
N1006 	Reference T7 MeSH:D018943	anthracyclines
T8	Pharmacological_substance 746 757	gemcitabine
N1007 	Reference T8 MeSH:C056507	gemcitabine
T9	Disorder 806 814	myositis
N1 	Reference T9 UMLS:C0027121	myositis
T10	Disorder 875 900	pancreatic adenocarcinoma
N2 	Reference T10 UMLS:C0281361	pancreatic adenocarcinoma
T11	Pharmacological_substance 1018 1029	gemcitabine
N1008 	Reference T11 MeSH:C056507	gemcitabine
T13	Disorder 1122 1134	inflammation
N3 	Reference T13 UMLS:C0021368	inflammation
T15	Disorder 1189 1199	dermatitis
N4 	Reference T15 UMLS:C0011603	dermatitis
T16	Disorder 1203 1212	mucositis
N5 	Reference T16 UMLS:C0333355	mucositis
T18	Disorder 1335 1345	dermatitis
N6 	Reference T18 UMLS:C0011603	dermatitis
T19	Pharmacological_substance 1361 1375	anthracyclines
N1009 	Reference T19 MeSH:D018943	anthracyclines
T20	Pharmacological_substance 1489 1500	gemcitabine
N1010 	Reference T20 MeSH:C056507	gemcitabine
T21	Pharmacological_substance 1529 1540	gemcitabine
N1011 	Reference T21 MeSH:C056507	gemcitabine
T22	Pharmacological_substance 1598 1609	doxorubicin
N1012 	Reference T22 MeSH:D004317	doxorubicin
T23	Disorder 1628 1654	radiation recall reactions
T24	Pharmacological_substance 1669 1680	gemcitabine
N1013 	Reference T24 MeSH:C056507	gemcitabine
T25	Disorder 1790 1812	cutaneous inflammation
N7 	Reference T25 UMLS:C3875321	cutaneous inflammation
N8 	Reference T25 UMLS:C0011603	cutaneous inflammation
T26	Disorder 1833 1861	internal tissue inflammation
T27	Disorder 127 149	inflammatory reactions
N9 	Reference T27 UMLS:C0021368	inflammatory reactions
T32	Pharmacological_substance 277 300	chemotherapeutic agents
N1014 	Reference T32 MeSH:D000970	chemotherapeutic agents
T33	Pharmacological_substance 335 342	taxanes
N1015 	Reference T33 MeSH:D043823	taxanes
T34	Pharmacological_substance 359 376	nucleotide analog
T35	Disorder 30 46	radiation recall
T37	Disorder 515 531	radiation recall
T38	Disorder 556 571	radiation recal
T39	Pharmacological_substance 670 677	taxanes
N1016 	Reference T39 MeSH:D043823	taxanes
T40	Disorder 719 735	radiation recall
T43	Disorder 926 942	radiation recall
T44	Disorder 998 1014	radiation recall
T47	Disorder 1281 1297	radiation recall
T48	Pharmacological_substance 1380 1387	taxanes
N1017 	Reference T48 MeSH:D043823	taxanes
T49	Pharmacological_substance 1573 1580	taxanes
N1018 	Reference T49 MeSH:D043823	taxanes
T52	Pharmacological_substance 1744 1763	other common agents
T54	Disorder 100 116	Radiation recall
T56	Coreferring_mention 631 636	those
T60	Subject 862 869	patient
